April 20, 2007 — Results of a randomized trial show a significant reduction in venous thromboembolism (VTE) events in stroke patients receiving the low-molecular-weight heparin enoxaparin ( Lovenox, ...

This is a preview. Log in through your library . Abstract OBJECTIVE To evaluate the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 ...

Objective: To compare the cost effectiveness of prophylaxiswith a low-molecular-weight heparin with that of prophylaxis withunfractionated heparin for the prevention of venous thromboembolismin ...

The anti-coagulant heparin reduces the likelihood of death from COVID-19 by 78% when administered in therapeutic doses to patients with signs of respiratory failure on admission to hospital, according ...

Please provide your email address to receive an email when new articles are posted on . Early administration of full-dose heparin slowed the thrombo-inflammatory process and reduced the risk for ...

Heparin-based thromboprophylaxis in obstetric patients did not reduce risk of venous thromboembolism (VTE), but may have increased the risks of other postpartum complications, a single-center ...

Posterior-Only Spinal Fusion Feasible in Parkinson’s Disease The risk of hemorrhage seems to be very low when prophylactic low-molecular-weight heparin (LMWH) is initiated 24-36 hours after ...

Early discharge from the hospital after total joint arthroplasty has increased the need for extended outpatient thromboprophylaxis. Multiple controlled clinical trials and several meta-analyses of ...